1375. In vitro Activity of Cefiderocol and Comparator Agents against Gram-Negative Isolates from Cancer Patients

BACKGROUND: Gram-negative bacilli (GNB) are now the predominant cause of bacterial infection in cancer patients (CP). Many GNB are problematic because they have become resistant to commonly used antibiotics. Cefiderocol (CFDC), a novel siderophore cephalosporin, is active against a wide spectrum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolston, Kenneth V I, Gerges, Bahgat, Raad, Issam, Aitken, Samuel L, Reitzel, Ruth, Prince, Randall
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252480/
http://dx.doi.org/10.1093/ofid/ofy210.1206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252480/
http://dx.doi.org/10.1093/ofid/ofy210.1206

Ejemplares similares